14 Cathie Wood Prime Medicine Trades
Cathie Wood's position in Prime Medicine is currently worth $20.2M. That's 0.14% of their equity portfolio (79th largest holding). The investor owns 3.47% of the outstanding Prime Medicine stock. The first Prime Medicine trade was made in Q4 2022. Since then Cathie Wood bought shares eight more times and sold shares on five occasions. The investor's estimated purchase price is $53.2M, resulting in a loss of 62%.
Avg closing price
Price range
Increased shares by 16.4% (+878k shares)
Q1 2026
Avg closing price
$3.94
Price range
$3.15
-
$4.68
Sold 2.0% shares (-109k shares)
Q4 2025
Avg closing price
$4.44
Price range
$3.30
-
$6.67
Increased shares by 135.8% (+3.16M shares)
Q3 2025
Avg closing price
$4.04
Price range
$2.73
-
$5.56
Sold 25.0% shares (-773k shares)
Q2 2025
Avg closing price
$1.54
Price range
$1.15
-
$2.65
Sold 39.9% shares (-2.06M shares)
Q1 2025
Avg closing price
$2.57
Price range
$1.72
-
$3.35
Sold 9.0% shares (-510k shares)
Q4 2024
Avg closing price
$3.50
Price range
$2.76
-
$4.46
Sold 7.6% shares (-466k shares)
Q3 2024
Avg closing price
$4.64
Price range
$3.41
-
$6.70
Increased shares by 2.2% (+133k shares)
Q2 2024
Avg closing price
$6.06
Price range
$4.30
-
$8.03
Increased shares by 91.0% (+2.86M shares)
Q1 2024
Avg closing price
$7.58
Price range
$6.35
-
$9.39
Increased shares by 19.7% (+516k shares)
Q4 2023
Avg closing price
$7.70
Price range
$5.59
-
$9.55
Increased shares by 7.1% (+173k shares)
Q3 2023
Avg closing price
$12.99
Price range
$9.50
-
$15.07
Increased shares by 27.4% (+527k shares)
Q2 2023
Avg closing price
$13.96
Price range
$11.41
-
$17.05
Increased shares by 17.2% (+282k shares)
Q1 2023
Avg closing price
$16.29
Price range
$11.21
-
$21.11
New holding (+1.64M shares)
Q4 2022
Avg closing price
$18.06
Price range
$15.20
-
$21.12
